Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal 2024-03-18 21:00
WuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adjusted Non-IFRS Net Profit Exceeded RMB10 Billion for the First Time 2024-03-18 20:32
Aquedeon Medical Announces First Patient Enrolled in the IDE Study of Duett(TM) Vascular Graft System 2024-03-18 20:00
EDAN and GH Labs Collaborate to Develop AI-Enabled Ultrasound Devices 2024-03-18 19:45
Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis 2024-03-18 19:25
KeChow Pharma Announces NMPA Approval of Tunlametinib (HL-085) as the First Targeted Therapy for Patients with NRAS Mutated Advanced Melanoma and Previously Treated with PD-1/PD-L1 2024-03-18 18:02
Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule 2024-03-18 18:00
Everest Medicines Strengthens Management Team with Appointments of Chief Medical Officer and Chief Product Officer 2024-03-18 09:00
Mediwave Earns Global Recognition at GLOMO Awards 2024 for Emergency Response HealthTech 2024-03-18 08:00
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration 2024-03-15 18:00
/C O R R E C T I O N -- Sisram Medical Ltd/ 2024-03-15 16:42
Novartis expands its biopharmaceutical manufacturing site in Singapore 2024-03-15 14:55
Qilu Pharmaceutical Showcases QL1706 Clinical Trial Outcomes in Oral Presentation at ESGO 2024 2024-03-15 14:07
ImmVira's oncolytic product MVR-T3011 IT Intratumoral Injection Receives FDA Fast Track Designation for HNSCC Treatment 2024-03-15 13:56
Seegene and Springer Nature Announce Awardees for the Open Innovation Program 2024-03-15 13:41
Biotheus Expanded Their Partnership with Hansoh Pharma for Developing EGFR/cMET Bispecific Antibody-Drug Conjugates 2024-03-15 12:34
CStone Announces the Fifth Indication Approved for Sugemalimab in China as First-Line Treatment for Gastric Cancer 2024-03-15 12:10
Advancing Healthcare in Uzbekistan: BGI Genomics CEO's Vision Shared on Uzbekistan's National Television 2024-03-15 07:55
I-Mab Reports Full Year 2023 Financial Results and Business Update 2024-03-15 05:00
D3 Bio Appoints Dr. Antoine Yver as Independent Board Member 2024-03-14 22:30
1 13 14 15 16 17 890